Episode

Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore

Podcast
Gynecologic Oncology Update
Published
Feb 9, 2026
Duration seconds
3296
Processing state
not_requested
Canonical source
https://gynecologic-oncology.captivate.fm/episode/5820-oncologytodayadcsovarian25
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/379d2bce-f4d9-4fe8-91a1-c12d3030594c.mp3
JSON
/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore
Markdown
/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-for-ovarian-cancer-an-interview-with-dr-kathleen-n-moore.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on available and novel treatment strategies with antibody-drug conjugates for ovarian cancer. CME information and select publications here .